- Home
- PYPD vs SUUN Comparison
PYPD vs SUUN Comparison
Compare PYPD & SUUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PYPD | SUUN |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.2M | 59.0M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PYPD | SUUN |
|---|---|---|
| Price | $3.95 | $1.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $12.00 | $5.00 |
| AVG Volume (30 Days) | 88.1K | ★ 428.0K |
| Earning Date | 11-12-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $32,753,484.00 |
| Revenue This Year | N/A | $127.67 |
| Revenue Next Year | N/A | $4.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.30 | $1.23 |
| 52 Week High | $4.07 | $6.43 |
Technical Indicators
Market Signals| Indicator | PYPD | SUUN |
|---|---|---|
| Relative Strength Index (RSI) | 58.01 | 50.84 |
| Support Level | $3.92 | $1.38 |
| Resistance Level | $4.05 | $1.72 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 65.71 | 64.71 |
Price Performance
Historical ComparisonAbout PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About SUUN SolarBank Corporation
SolarBank Corp is an independent renewable and clean energy project developer, power producer, and asset operator in Canada and the United States, with the majority of its revenue coming from the United States. The Company operates through two reportable segments: Development and EPC, which involves the development and construction of solar photovoltaic power projects, and IPP Production, which includes the operation of solar power and battery energy storage systems. Corporate and other activities cover operation, maintenance, and repairs. The majority of revenue is generated from the Development and EPC segment.